Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Exp Eye Res ; 212: 108786, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34624334

RESUMEN

PURPOSE: The purpose of this study is to examine the effect of short-wavelength blue light (SWBL) on cultured human lens epithelial cells (hLECs). The pathogenesis of cataracts after SWBL exposure is discussed. METHODS: HLE-B3 hLECs were randomly divided into 3 groups: the NC group, which was grown in a dark incubator; the acetyl (Ac)-Tyr-Val-Ala-Asp-chloromethyl ketone (AC-YVAD-CMK) treatment group; and the SWBL exposure group. After SWBL (2500 lux) irradiation (for 8, 16, 24, and 32 h), caspase-1 and gasdermin D (GSDMD) expression levels in HLE-B3 hLECs were examined using ELISA, immunofluorescence staining, and Western blotting analyses. Double-positive staining of hLECs for activated and inhibited caspase-1 was used to determine pyroptosis in HLE-B3 hLECs. RESULTS: SWBL led to hLEC death, but a caspase-1 inhibitor suppressed cell death. The flow cytometry results also confirmed the dose-dependent effect of SWBL irradiation on the pyroptotic death of hLECs. Caspase-1 and GSDMD expression levels in all hLEC groups changed with blue light exposure times (8, 16, 24, and 32 h) and were higher in the AC-YVAD-CMK and SWBL exposure groups than in the NC group. The immunofluorescence results revealed higher GSDMD-N expression in the cell membrane of both the AC-YVAD-CMK and SWBL exposure groups than in the NC group. CONCLUSIONS: Based on the data, SWBL induces pyroptotic programmed cell death by activating the GSDMD signalling axis in HLE-B3 hLECs. These results provide new insights into the exploitation of new candidates for the prevention of cataracts.


Asunto(s)
Catarata/radioterapia , Células Epiteliales/patología , Cristalino/patología , Luz , Piroptosis/efectos de la radiación , Western Blotting , Catarata/metabolismo , Catarata/patología , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Células Epiteliales/metabolismo , Células Epiteliales/efectos de la radiación , Citometría de Flujo , Cristalino/metabolismo , Cristalino/efectos de la radiación , Estimulación Luminosa/métodos
2.
Ann ICRP ; 47(3-4): 196-213, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29741403

RESUMEN

Radiation therapy of cancer patients involves a trade-off between a sufficient tumour dose for a high probability of local control and dose to organs at risk that is low enough to lead to a clinically acceptable probability of toxicity. The International Commission on Radiological Protection (ICRP) reviewed epidemiological evidence and provided updated estimates of 'practical' threshold doses for tissue injury, as defined at the level of 1% incidence, in ICRP Publication 118. Particular attention was paid to cataracts and circulatory diseases. ICRP recommended nominal absorbed dose threshold for these outcomes as low as 0.5 Gy. Threshold doses for tissue reactions can be reached in some patients during radiation therapy. Modern treatment planning systems do not account for such low doses accurately, and doses to therapy patients from associated imaging procedures are not generally accounted for. While local control is paramount, the observations of ICRP Publication 118 suggest that radiation therapy plans and processes should be examined with particular care. The research needs are discussed in this paper.


Asunto(s)
Enfermedades Cardiovasculares/radioterapia , Catarata/radioterapia , Protección Radiológica/normas , Radioterapia/normas , Incidencia , Agencias Internacionales , Medición de Riesgo/normas
3.
Curr Eye Res ; 42(7): 987-994, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28632030

RESUMEN

PURPOSE: Nuclear factor-kappa B (NF-κB) has been proposed as a therapeutic target for the treatment of cataracts. The authors investigated the relationship between nuclear factor of activated T cells 5 (NFAT5) and NF-κB in ultraviolet B (UVB)-irradiated human lens epithelial (HLE) cells. METHODS: Human lens epithelial B-3 (HLE-B3) cells were exposed to UVB light at a dose of 10 mJ/cm2 and then incubated for 24 h. Cell viability was assessed by using the Cell Counting Kit-8 (CCK-8) assay. Gene expression level of NFAT5 was determined using real-time quantitative polymerase chain reaction (qPCR). Protein expression levels of NFAT5, NF-κB p65, and α-smooth muscle actin (α-SMA) and the association of NFAT5 with the NF-κB p65 subunit were measured by Western blot analysis and a co-immunoprecipitation assay, respectively. The cellular distribution of NFAT5 and NF-κB p65 was examined by triple immunofluorescence staining. RESULTS: At 24 h after UVB exposure, cell viability significantly decreased in a dose-dependent manner, and UVB light (15 and 20 mJ/cm2) significantly increased the ROS generation. UVB irradiation increased NFAT5 mRNA and protein levels and increased phosphorylation of NF-κB in HLE-B3 cells. α-SMA protein levels were increased in the irradiated cells. In addition, NFAT5 and NF-κB translocated from the cytoplasm to the nucleus, and binding between the p65 subunit and NFAT5 was increased. CONCLUSIONS: Exposure to UVB radiation induces nuclear translocation and stimulates binding between NFAT5 and NF-κB proteins in HLE-B3 cells. These interactions may form part of the biochemical mechanism of cataractogenesis in UVB-irradiated HLECs.


Asunto(s)
Catarata/genética , Regulación de la Expresión Génica , Cápsula del Cristalino/metabolismo , FN-kappa B/genética , Factores de Transcripción NFATC/genética , ARN/genética , Rayos Ultravioleta , Western Blotting , Catarata/patología , Catarata/radioterapia , Supervivencia Celular , Células Cultivadas , Inmunohistoquímica , Inmunoprecipitación , Líquido Intracelular/metabolismo , Cápsula del Cristalino/patología , Cápsula del Cristalino/efectos de la radiación , Microscopía Confocal , FN-kappa B/biosíntesis , FN-kappa B/efectos de la radiación , Factores de Transcripción NFATC/biosíntesis , Factores de Transcripción NFATC/efectos de la radiación , Especies Reactivas de Oxígeno/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa
4.
Vestn Oftalmol ; 114(3): 45-6, 1998.
Artículo en Ruso | MEDLINE | ID: mdl-9720402

RESUMEN

Five-minute ultrasonic exposure of 0.4 Wt/cm2 intensity and 880 kHz frequency at acoustic contact through isotonic NaCl solution in the permanent mode (10-15 sessions) in combination with exposure to sinusoidal alternating 50-period magnetic field for up to 20 min had a positive stable therapeutic effect in patients with initial and immature senile cataracts, decelerating the processes of maturing. A course of treatment consisted of regular annual therapy according to the above protocol. The best results were attained in the group treated at the sanatorium and administered a course of complex spa therapy; this is one more confirmation that senile cataract is a dysfunction of the ageing organism suffering from many diseases requiring total-systems treatment in addition to the treatment for cataract.


Asunto(s)
Catarata/terapia , Anciano , Catarata/etiología , Catarata/radioterapia , Femenino , Estudios de Seguimiento , Humanos , Terapia por Láser , Magnetismo/uso terapéutico , Masculino , Persona de Mediana Edad , Factores de Tiempo
5.
Vestn Oftalmol ; 111(3): 17-9, 1995.
Artículo en Ruso | MEDLINE | ID: mdl-7483194

RESUMEN

Lipid peroxidation products, antioxidant system parameters, somatotrophic hormone, corticosteroids, fibronectin, and cyclic nucleotides were measured in the blood of 119 patients with open-angle glaucoma and mature senile cataract before and after a course of exposure of the eyeball to He-Ne laser. Statistically significant changes in the examined parameters were revealed, explaining to a great measure the antiinflammatory and vasodilating effects of laser and its ability to intensify the repair processes.


Asunto(s)
Catarata/radioterapia , Ojo/efectos de la radiación , Glaucoma de Ángulo Abierto/radioterapia , Terapia por Láser , Corticoesteroides/sangre , Anciano , Anciano de 80 o más Años , Antioxidantes , Catarata/sangre , Catarata/metabolismo , Estudios de Evaluación como Asunto , Femenino , Fibronectinas/sangre , Glaucoma de Ángulo Abierto/sangre , Glaucoma de Ángulo Abierto/metabolismo , Hormona del Crecimiento/sangre , Humanos , Peroxidación de Lípido , Masculino , Persona de Mediana Edad , Nucleótidos Cíclicos/sangre
6.
Nuklearmedizin ; 51(3): 79-83, 2012.
Artículo en Alemán | MEDLINE | ID: mdl-22395665

RESUMEN

AIM: Current reports for the radiation cataracts contained a warning for deterministic effects at 1-2 Gy radiation single exposure for lens. Recently, the German Radiation Protection Board (SSK) published a document (234. SSK-Board) in that threshold dose for radiation cataracts is claimed at 0.5 Gy. The lens of the eye is recognized as one of the most radiosensitive tissues in the human body, and the International Commission on Radiological Protection (ICRP 103) has defined a limit of 150 mSv for its exposure.Recently, the ICRP lowered this limit down to 20 mSv per year.However, this limit does not apply to patients. Therefore, the question of the lens radiation exposure for patients underwent a radioiodine therapy (RIT) is a point at issue. PATIENTS, METHODS: A total of 41 patients (age: 22-92 years) underwent a radioiodine therapy were included in the study. Optical stimulated luminescence dosimeters were used to measure the radiation exposure. The dosimeters were fastened nearby the patient's eye lens. The measurement was carried out up to 48 h after radioiodine application and the patients were divided into three groups. Group 1: patients underwent a diagnostic 131I whole body scan (mean activity: 370 MBq); group 2: thyriod carcinoma patients under RIT (mean activity: 3700 MBq); group 3: hyperthyroid patients under RIT (activity: 180-1237 MBq). RESULTS: The cumulative exposure of the eye lens during the stay at the therapy unit (48 h) was 4.8 ± 0.7 mGy in group 1, 24.5-50.5 mGy in group 2 and 2.7-26.3 mGy in group 3, respectively. For the calculation of the expected cumulative dose, including follow-up after patient's dismissal, the effective half-lives were involved. The cumulative doses were obtained to be 6 ± 1 mGy in the first group, 63 ± 15 mGy in the second and 5-148 mGy in the third. CONCLUSION: The results show that there exists a low risk for radiation cataract in a nuclear medicine therapy unit. After serial radioiodine therapies radiation-induced lens opacity cannot be expected.


Asunto(s)
Catarata/radioterapia , Radioisótopos de Yodo/análisis , Radioisótopos de Yodo/uso terapéutico , Cristalino , Dosis de Radiación , Radiometría , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Radiofármacos/análisis , Radiofármacos/uso terapéutico , Medición de Riesgo
9.
Biochem Mol Biol Int ; 42(6): 1189-97, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9305537

RESUMEN

The effect of several antioxidants and cysteine-elevating precursor drugs (prodrugs) was tested on lens damage occurring after in vitro exposure to low levels of 60Co-gamma-irradiation, to simulate in vitro the exposure to radiation in vivo of (1) astronauts (2) jet crews (3) military radiation accident personnel. Tocopherol (100 microM), ascorbic acid (1 mM), R-alpha-lipoic acid (1 mM), and taurine (0.5 mM) protected against radiation-associated protein leakage. MTCA and ribocysteine protected lenses against opacification, LDH and protein leakage, indicating that antioxidants and prodrugs of cysteine appear to offer protection against lens damage caused by low level radiation.


Asunto(s)
Antioxidantes/farmacología , Catarata/fisiopatología , Cristalino/efectos de los fármacos , Cristalino/efectos de la radiación , Protectores contra Radiación/farmacología , Animales , Ácido Ascórbico/farmacología , Carbolinas/farmacología , Catarata/radioterapia , Cisteína/análogos & derivados , Cisteína/farmacología , Relación Dosis-Respuesta en la Radiación , Técnicas In Vitro , L-Lactato Deshidrogenasa/efectos de los fármacos , L-Lactato Deshidrogenasa/metabolismo , L-Lactato Deshidrogenasa/efectos de la radiación , Enfermedades Profesionales , Ratas , Ribosa/análogos & derivados , Ribosa/farmacología , Taurina/farmacología , Ácido Tióctico/farmacología , Vitamina E/análogos & derivados , Vitamina E/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA